dextroamphetamine has been researched along with Migraine Disorders in 9 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To present two other dermatologic conditions related to a disorder of sympathetic nervous system hypofunction common in women that respond to treatment with dextroamphetamine sulfate--chronic eczema and keratosis pilaris." | 7.80 | Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate. ( Chan, S; Check, JH, 2014) |
| "To present two other dermatologic conditions related to a disorder of sympathetic nervous system hypofunction common in women that respond to treatment with dextroamphetamine sulfate--chronic eczema and keratosis pilaris." | 3.80 | Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate. ( Chan, S; Check, JH, 2014) |
| " By measuring the brain function using computer period analysis of cerebral biopotentials, dose-efficacy relations were found (in the range of 25-75 mcg) which suggest the bioavailability of LHM at the CNS level." | 2.64 | Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram. ( Akpinar, S; Herrmann, WM; Itil, TM, 1975) |
| "The chronic migraine headaches almost completely disappeared shortly following therapy." | 1.39 | Dihydrotestosterone may contribute to the development of migraine headaches. ( Check, JH; Cohen, R, 2013) |
| "A woman with severe migraine headaches resistant to standard therapy was treated with dextroamphetamine sulfate." | 1.37 | Marked improvement of headaches and vasomotor symptoms with sympathomimetic amines in a woman with sympathetic hyperalgesia-edema syndrome. ( Check, JH; Cohen, R, 2011) |
| "Dextroamphetamine sulfate was prescribed to a 33-year-old woman with intractable migraine headaches resistant to standard therapy." | 1.37 | Evidence that migraine headaches in women may be related to a common defect in the sympathetic nervous system as evidenced by marked improvement following treatment with sympathomimetic amines. ( Check, D; Check, JH; Cohen, R, 2011) |
| "Two cases with severe migraines resistant to conventional therapy were evaluated to see the response to dextroamphetamine sulfate." | 1.35 | Sympathomimetic amine therapy may markedly improve treatment resistant headaches related to a vascular permeability defect common in women--presentation of two cases. ( Check, D; Check, JH; Cohen, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Check, JH | 6 |
| Jaffe, A | 1 |
| Cohen, R | 4 |
| Chan, S | 1 |
| Check, D | 2 |
| SHELLEY, WB | 1 |
| RESNIK, SS | 1 |
| Gupta, VK | 1 |
| Itil, TM | 1 |
| Herrmann, WM | 1 |
| Akpinar, S | 1 |
1 trial available for dextroamphetamine and Migraine Disorders
| Article | Year |
|---|---|
Prediction of psychotropic properties of lisuride hydrogen maleate by quantitative pharmaco-electroencephalogram.
Topics: Adolescent; Adult; Aged; Biological Availability; Child; Child, Preschool; Clinical Trials as Topic; | 1975 |
8 other studies available for dextroamphetamine and Migraine Disorders
| Article | Year |
|---|---|
Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy.
Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Depression, Postpartum; Dextroamphe | 2017 |
Dihydrotestosterone may contribute to the development of migraine headaches.
Topics: 5-alpha Reductase Inhibitors; Contraceptives, Oral; Dextroamphetamine; Dihydrotestosterone; Female; | 2013 |
Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate.
Topics: Abnormalities, Multiple; Chronic Disease; Darier Disease; Dextroamphetamine; Eczema; Eyebrows; Fatig | 2014 |
Sympathomimetic amine therapy may markedly improve treatment resistant headaches related to a vascular permeability defect common in women--presentation of two cases.
Topics: Adult; Dextroamphetamine; Female; Humans; Middle Aged; Migraine Disorders; Sympathomimetics | 2009 |
Marked improvement of headaches and vasomotor symptoms with sympathomimetic amines in a woman with sympathetic hyperalgesia-edema syndrome.
Topics: Adult; Dextroamphetamine; Edema; Female; Humans; Hyperalgesia; Migraine Disorders | 2011 |
Evidence that migraine headaches in women may be related to a common defect in the sympathetic nervous system as evidenced by marked improvement following treatment with sympathomimetic amines.
Topics: Adult; Autonomic Nervous System Diseases; Dextroamphetamine; Edema; Female; Humans; Migraine Disorde | 2011 |
METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN.
Topics: Basophils; Biomedical Research; Chloroquine; Dextroamphetamine; Drug Therapy; Histamine Release; Hum | 1964 |
Amphetamine, migraine, and brain noradrenergic activation: contradictions in headache research.
Topics: Brain; Brain Chemistry; Caffeine; Central Nervous System Stimulants; Contraindications; Cross-Over S | 2006 |